NGX267

· TorreyPines Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NGX267, covering 2009-01-29 to 2009-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome [Phase 2]